Preeclampsia: New study documents its enormous economic and health burden

Rates of preeclampsia are rising rapidly, yet surprisingly there are few national estimates of the health and economic impact of preeclampsia on mothers and their infants. A new study provides sobering data on this topic by examining the short-term costs associated with the condition. Significantly increasing the chance of adverse health outcomes, preeclampsia accounts for over $2.18 billion of health care expenditure in the first 12 months after birth.